Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$1.49M Sell
29,294
-1,040
-3% -$51.8K 0.58% 62
2015
Q4
$1.53M Hold
30,334
0.61% 60
2015
Q3
$1.46M Buy
30,334
+5,680
+23% +$296K 0.61% 58
2015
Q2
$1.28M Sell
24,654
-4,684
-16% -$264K 0.49% 70
2015
Q1
$1.69M Sell
29,338
-320
-1% -$18.3K 0.6% 57
2014
Q4
$1.58M Sell
29,658
-136
-0.5% -$7.61K 0.55% 60
2014
Q3
$1.71M Sell
29,794
-6,640
-18% -$407K 0.62% 55
2014
Q2
$2.44M Hold
36,434
0.84% 40
2014
Q1
$2.43M Sell
36,434
-191
-0.5% -$12.9K 0.87% 38
2013
Q4
$2.44M Sell
36,625
-1,005
-3% -$65.2K 0.87% 39
2013
Q3
$2.36M Buy
37,630
+900
+2% +$57.9K 0.91% 37
2013
Q2
$2.29M Buy
+36,730
New +$2.33M 0.92% 37

Other funds holding GSK

Spectrum Advisory Services's GSK Position: Q1 2016 in Review

Spectrum Advisory Services reduced its GSK (GSK) stake by 3.4% in Q1 2016, selling an estimated $51.8K and leaving 29,294 shares worth $1.49M. The position accounts for 0.58% of the portfolio, ranked #62.

Spectrum Advisory Services first reported a position in GSK in Q2 2013 and has held it in 12 quarters since. The position peaked at $2.44M in Q4 2013. 726 funds tracked by Wall St. Rank hold GSK as of Q1 2016.

  • Spectrum Advisory Services held 29,294 shares of GSK worth $1.49M as of Q1 2016.
  • Spectrum Advisory Services sold 1,040 GSK shares in Q1 2016, an estimated $51.8K.
  • GSK made up 0.58% of Spectrum Advisory Services's portfolio in Q1 2016, its #62 holding.
  • Spectrum Advisory Services first reported a position in GSK in Q2 2013 and has held it in 12 quarters since.
  • Spectrum Advisory Services's GSK position peaked at $2.44M in Q4 2013.
  • 726 funds tracked by Wall St. Rank held GSK as of Q1 2016.

Based on Spectrum Advisory Services's 13F filing for Q1 2016, filed 12 May 2016.